Ocean Biomedical Inc (NASDAQ:OCEA)’s traded shares stood at 22.78 million during the last session, with the company’s beta value hitting 1.59. At the close of trading, the stock’s price was $0.06, to imply an increase of 2.89% or $0.0 in intraday trading. The OCEA share’s 52-week high remains $4.97, putting it -8183.33% down since that peak but still an impressive 0.0% since price per share fell to its 52-week low of $0.06. The company has a valuation of $8.51M, with an average of 12.8 million shares in intraday trading volume over the past 10 days and average of 34.98 million shares over the past 3 months.

Ocean Biomedical Inc (NASDAQ:OCEA) trade information

After registering a 2.89% upside in the last session, Ocean Biomedical Inc (OCEA) has traded red over the past five days. The 5-day price performance for the stock is -22.93%, and -54.10% over 30 days. With these gigs, the year-to-date price performance is -89.06%. Short interest in Ocean Biomedical Inc (NASDAQ:OCEA) saw shorts transact 5.72 million shares and set a 0.07 days time to cover.

OCEA Dividends

Ocean Biomedical Inc has its next earnings report out on 2024-Apr-14. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.

Ocean Biomedical Inc (NASDAQ:OCEA)’s Major holders

Ocean Biomedical Inc insiders hold 17.04% of total outstanding shares, with institutional holders owning 2.60% of the shares at 3.13% float percentage. In total, 2.60% institutions holds shares in the company.

We also have Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund as the top two Mutual Funds with the largest holdings of the Ocean Biomedical Inc (OCEA) shares. Going by data provided on Dec 31, 2024, Vanguard Total Stock Market Index Fund holds roughly 243.67 shares. This is just over 0.17% of the total shares, with a market valuation of $14742.0. Data from the same date shows that the other fund manager holds a little less at 156.2, or 0.11% of the shares, all valued at about 9450.0.